ArticleFrontiers in oncology2021

Homologous Recombination Deficiency Associated With Response to Poly (ADP-ribose) Polymerase Inhibitors in Ovarian Cancer Patients: The First Real-World Evidence From China.

Jing Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.